204 related articles for article (PubMed ID: 31248720)
1. Autoimmune pancreatitis not otherwise specified (NOS): Clinical features and outcomes of the forgotten type.
de Pretis N; Vieceli F; Brandolese A; Brozzi L; Amodio A; Frulloni L
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):576-579. PubMed ID: 31248720
[TBL] [Abstract][Full Text] [Related]
2. Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency.
Barresi L; Tacelli M; Crinò SF; Attili F; Petrone MC; De Nucci G; Carrara S; Manfredi G; Capurso G; De Angelis CG; Crocellà L; Fantin A; Dore MF; Garribba AT; Tarantino I; De Pretis N; Pagliari D; Rossi G; Manes G; Preatoni P; Barbuscio I; Tuzzolino F; Traina M; Frulloni L; Costamagna G; Arcidiacono PG; Buscarini E; Pezzilli R;
United European Gastroenterol J; 2020 Jul; 8(6):705-715. PubMed ID: 32397913
[TBL] [Abstract][Full Text] [Related]
3. Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A Single-Center Experience.
Oh D; Song TJ; Moon SH; Kim JH; Lee NJ; Hong SM; Lee JS; Jo SJ; Cho DH; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
Gut Liver; 2019 Apr; 13(4):461-470. PubMed ID: 30970429
[TBL] [Abstract][Full Text] [Related]
4. The features and clinical outcomes of inflammatory bowel disease associated with autoimmune pancreatitis: A greater awareness is needed.
Conti Bellocchi MC; Marconato E; Lamonaca L; Cattani Mottes M; Ciccocioppo R; Carrara S; de Pretis N; Gabbrielli A; Crinò SF; Frulloni L
Medicine (Baltimore); 2022 Jan; 101(4):e28602. PubMed ID: 35089195
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis.
de Pretis N; Carlin M; Calderini E; Caldart F; Conti Bellocchi MC; Amodio A; De Marchi G; Campagnola P; Crinò SF; Bernardoni L; Gabbrielli A; Martinelli L; Frulloni L
United European Gastroenterol J; 2024 Apr; 12(3):319-325. PubMed ID: 38217278
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Pancreatitis: From Pathogenesis to Treatment.
Nista EC; De Lucia SS; Manilla V; Schepis T; Pellegrino A; Ojetti V; Pignataro G; Zileri Dal Verme L; Franceschi F; Gasbarrini A; Candelli M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293522
[TBL] [Abstract][Full Text] [Related]
7. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis.
Song TJ; Kim JH; Kim MH; Jang JW; Park DH; Lee SS; Seo DW; Lee SK; Yu E
J Gastroenterol Hepatol; 2012 Apr; 27(4):700-8. PubMed ID: 21929653
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature.
Nikolic S; Lanzillotta M; Panic N; Brismar TB; Moro CF; Capurso G; Della Torre E; Löhr JM; Vujasinovic M
United European Gastroenterol J; 2022 Jun; 10(5):496-506. PubMed ID: 35526270
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis.
Tacelli M; Celsa C; Magro B; Barresi L; Guastella S; Capurso G; Frulloni L; Cabibbo G; Cammà C
Clin Gastroenterol Hepatol; 2019 May; 17(6):1061-1072.e8. PubMed ID: 30312787
[TBL] [Abstract][Full Text] [Related]
11. Sialadenitis in a patient with ulcerative colitis and autoimmune pancreatitis type 2.
Detlefsen S; Olesen SS
Pathol Res Pract; 2020 Sep; 216(9):153072. PubMed ID: 32825945
[TBL] [Abstract][Full Text] [Related]
12. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune pancreatitis: Cornerstones and future perspectives.
Gallo C; Dispinzieri G; Zucchini N; Invernizzi P; Massironi S
World J Gastroenterol; 2024 Feb; 30(8):817-832. PubMed ID: 38516247
[TBL] [Abstract][Full Text] [Related]
14. [A young woman with auto-immune pancreatitis].
Zoutendijk R; van Santvoort HC; Raicu MG; Bollen TL; Verdonk RC
Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928874
[TBL] [Abstract][Full Text] [Related]
15. Type 2 autoimmune pancreatitis associated with ulcerative colitis.
Nan N; Wang D
Front Immunol; 2023; 14():1288390. PubMed ID: 38124742
[TBL] [Abstract][Full Text] [Related]
16. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
17. Updates in the field of autoimmune pancreatitis: a clinical guide.
de Pretis N; Amodio A; Frulloni L
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):705-709. PubMed ID: 29923430
[TBL] [Abstract][Full Text] [Related]
18. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
Masamune A; Kikuta K; Hamada S; Tsuji I; Takeyama Y; Shimosegawa T; Okazaki K;
J Gastroenterol; 2020 Apr; 55(4):462-470. PubMed ID: 31872350
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population.
Liu B; Li J; Yan LN; Sun HR; Liu T; Zhang ZX
World J Gastroenterol; 2013 Jan; 19(4):569-74. PubMed ID: 23382638
[TBL] [Abstract][Full Text] [Related]
20. Duct-obstructive pancreatitis with granulocytic epithelial lesion in a patient with ulcerative colitis: An atypical manifestation of type 2 autoimmune pancreatitis?
Ahn S; Lee JC; Hwang JH; Yoon YS; Lee KH; Zen Y
Pathol Int; 2019 Jul; 69(7):420-426. PubMed ID: 31219205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
